Gudanar da Jigilar jini yana da mahimmanci ga masu ciwon sukari
Yin amfani da karfin jini yana da mahimmanci ga masu lafiya na ciwon sukari. Rashin hawan cutar hawan jini a cikin masu ciwon sukari yana da matukar tsanani cewa wasu nazarin sun nuna cewa jinin karfin jini a cikin marasa lafiya na ciwon sukari yana haifar da tasiri mai karfi a kan lafiyar jiki na tsawon lokaci (ingancin rayuwa, yawan rikitarwa, rayuwa mai mahimmanci) fiye da jinin jini Tsarin sukari.
Yayinda wannan ba ya nufin ya kamata ka watsar da burin jinin ka, zai karfafa ra'ayin cewa sarrafa jini yana da mahimmanci manufa.
Jiyya Goals
A yayin da ake ci gaba da ciwon sukari, jinin jini yana da kasa da 130/80. An yi nazari sosai game da matsalolin jinin jini, kuma yawancin bincike sun nuna cewa ci gaba mai mahimmanci a cikin lafiyar zuciya da na koda cikin dogon lokaci bazai zama ba sai dai an rage karfin jini zuwa wannan matakin. Saboda wannan dalili, likitoci sun kasance suna da mummunan zalunci a lokacin da suke tsara tsarin kula da marasa lafiya na masu ciwon sukari.
Wasu nazarin sun nuna cewa wasu kungiyoyin marasa lafiya na ciwon sukari - kamar waɗanda suke da matsaloli na koda-kullun - suna amfani da mafi yawancin matsalolin jini fiye da 120/80. Bayanai sun nuna cewa hadarin cututtuka na zuciya da jijiyoyin ƙwayar ƙwayar kodafa sunyi la'akari da dabi'u mafi ƙasƙanci a cikin wannan kewayon.
Domin yana da wuyar rage yawan jini zuwa wannan matakin, yana da shawarar da aka adana kawai ga marasa lafiya.
Magunguna marasa lafiya
Bayanin jagorancin Ƙungiyar Zuciya ta Amurka da Ƙungiyar Ciwon Ciwon Ciwon Gida ta Amurka sun bayyana cewa za'a fara magance matsalolin jini a cikin layin 130-139 / 80-89 tare da "ba-pharmacologic" (babu magani).
Waɗannan zaɓuɓɓuka sun haɗa da:
- Asarar nauyi
- Ƙuntataccen gishiri
- Sauye-sauyen abinci
- Quitting shan taba
- Ƙayyade barasa
A marasa lafiya ba tare da ciwon sukari ba, tsayayyar wa annan dokoki sau da yawa yakan haifar da ƙananan saukad da cutar karfin jini, don haka ba za'a bukaci maganin likita ba. Duk da yake wannan zai iya faruwa a cikin marasa lafiya na ciwon sukari, ba shi da mawuyacin hali, kuma yawancin magani ana buƙata. Wadannan canje-canje har yanzu suna da darajar, duk da haka, saboda suna ƙara inganta tasirin maganin miyagun ƙwayoyi kuma hakan yana haifar da kyakkyawan tsarin karfin jini.
Drug Far
Drug far ne muhimmin mataki ga mafi yawan marasa lafiya a wani lokaci a lokacin magani. An yi bincike mai zurfi a cikin ƙoƙari na ƙayyade abin da miyagun ƙwayoyi ko magungunan miyagun ƙwayoyi ke "mafi kyau" don magance cutar hawan jini a cikin marasa lafiya da ciwon sukari. Ko da yake binciken binciken ya bambanta kadan, akwai yarjejeniya ta kusa da duniya cewa mafi kyau maganin da za a yi amfani da shi a cikin tsarin ciwon sukari shine:
Wadannan kwayoyi suna magance matsalolin da ke tattare da cutar hawan jini a cikin saitin ciwon sukari ciki har da fadada ƙararrawa , karfin jini, da lalacewar koda. Kodayake wasu likitoci sun fara farfadowa ta hanyar ƙoƙarin yin amfani da su a kan kansa, yana da mahimmanci don farawa tare da mai hana ACE.
Daga ƙarshe, wasu masu haɗin ACE / ARB haɗuwa ne yawancin maganin zaɓin, tare da ƙarin diuretic idan an buƙata. Ko da yake wannan ita ce magani mafi magungunan magani, wasu magungunan za a iya haɗa su dangane da wasu dalilai masu haƙuri.
Idan likita ya zaɓa don fara farfadowa tare da diuretic, ku sani cewa wannan ba zabin ba ne, kuma akwai shaidar da za ta goyi bayan wannan shawarar a wasu nau'in marasa lafiya. Zai bayyana sosai da sauri ko magani yana aiki ko a'a, kuma za a yi gyare-gyare idan ya cancanta.
Biyan Kula
Duk abin da aka gudanar na musamman, kulawa mai kyau yana da mahimmanci ga gudanar da farfadowar zaman lafiya na dogon lokaci.
Da farko, za ku iya ganin likitanku kowane wata, ko ma bi-mako, har sai an shirya shirin da ya dace. Bayan haka, likitocin da yawa za su nemi ku dawo a kowane wata uku don shekara ta farko. Wannan ya biyo baya yana amfani da shi don biyan canje-canje a cikin karfin jini kuma kafa kafaccen tsari don wasu matakan jiki kamar matakan electrolyte (potassium da sodium cikin jini) da aikin koda.
Bayan shekara ta farko, likita zai iya zaɓar ya canza zuwa alƙawuran watanni shida, ko kuma yana so ka ci gaba a cikin watanni uku. Idan an umarce ku don ci gaba da jimlar watanni uku, wannan ba abin dalili ba ne, to yana nufin cewa ana bukatar ƙarin lokaci don tabbatar da cewa duk abin da ke faruwa kamar yadda aka tsara. Ƙara yawan likitoci suna neman duk masu ciwon sukari da cutar hawan jini don su zo cikin kowane wata uku. Tsayawa ga waɗannan alƙawarin yana da mahimmanci. Jiyya yana da mahimmanci idan aka haɗa tare da jadawalin kulawa mai kyau.
Sources:
Sakamakon mahimmanci a cikin marasa lafiya mai karfin jini wanda bazata ba ne zuwa ga angiotensin-canza mai hana magungunan enzyme ko mai kwakwalwa mai kwakwalwa tare da diuretic: Tsarin antihypertensive da maganin maganin Lipid don hana Gwajin Zuciya (ALLHAT). JAMA 2002; 288: 2981.
Buse, JB, Ginsberg, HN, Bakris, GL, et al. Yin rigakafi na farko na cututtuka na zuciya da jijiyoyin jini a cikin mutanen da ke fama da ciwon sukari: bayanin kimiyya daga Ƙungiyar Zuciya ta Amirka da Cibiyar Ciwon Ciwon Gida ta Amirka. Yanayi 2007; 115: 114.
Gaede, P, Vedel, P, Parving, HH, Pedersen, O. Magunguna masu yawa da dama da masu ciwon sukari 2 da kuma microalbuminuria: Nazarin nazarin binciken na Steno type 2. Lancet 1999; 353: 617.
Zillich, AJ, Garg, J, Basu, S, et al. Thiazide diuretics, potassium, da kuma ci gaba da ciwon sukari: nazarin yawa. Hawan jini na shekarar 2006; 48: 219.
Daly, CA, Fox, KM, Remme, WJ, et al. Halin cututtuka akan cututtuka na zuciya da jijiyoyin jini da kuma mace-mace a cikin marasa lafiya da ciwon sukari a cikin binciken EUROPA: sakamakon daga PERSUADE substudy. Eur Heart J 2005; 26: 1369.
Brenner, BM, Cooper, ME, de Zeeuw, D, et al. Rabin losartan a kan ƙwayar cuta da kuma na zuciya da jijiyoyin jini a marasa lafiya tare da irin 2 ciwon sukari da kuma nephropathy. N Engl J Med 2001; 345: 861.
Ƙungiyar Ciwon Yankakken Amirka. Gubar da hawan hawan jini a cikin Manya da ciwon sukari. Ciwon sukari Care 2004; 27 (Sanya 1): S65.